莱姆病螺旋体重组质粒pBX1的DNA序列分析及其在大肠杆菌中的诱导表达

目的　为莱姆病血清学诊断和基因工程亚单位疫苗研制提供靶抗原。方法　采用 377型 DNA自动测序仪对莱姆病螺旋体重组质粒 p BX1的插入片段进行 DNA序列测定 ,并通过计算机软件对其进行限制性内切酶酶谱分析。然后将重组质粒 p BX1在大肠杆菌中进行诱导表达 ,并对其表达产物进行免疫印迹分析。结果　1重组质粒 p BX1插入片段大小为 477bp,其核苷酸序列与文献报道的 p83基因全序列相应区段相比较仅有一个碱基的变异 ,2成功绘制了该插入片段的限制性内切酶酶谱 ;3重组质粒在大肠杆菌中诱导表达后获得了 2 9kd的融合蛋白 ;4Western- blotting分析表明该融合蛋白能与莱姆病多价抗血清呈强阳性印迹反应。结论　该研究成功地对莱姆病螺旋体 83kd抗原蛋白特异性区段进行了基因重组和表达 ,为进一步研究其在莱姆病血清学诊断和基因工程亚单位疫苗研制中的应用奠定了基础。

DNA Sequence Analysis and Expression of the Recombinant Plasmid pBX1 from Borrelia Burgdorferi B31 Strain

Objective　This study was to provide the target antigen for the development of a Lyme disease vaccine and serodiagnosis reagent.Methods　We used the automatic DNA sequencing machine (Model 377) to detect the nucleotide sequence of the inserted part of the recombinant plasmid pBX1 from Borrelia burgdorferi B31 strain. The restriction enzyme map of the inserted part of pBX1 was analysed by using computer software. The expressed product of pBX1 in E.coli XLI-Blue MRF′ was analysed by using SDS-PAGE and western-blotting. Results　①DNA sequencing showed that pBX1 contained a 477bp inserted gene fragment,and when it was compared with the published sequence of the specific region of the gene of the 83kd antigen protein from Borrelia burgdorferi B31 strain,only one amino acid codon was different.②The restriction enzyme map of the inserted part of pBX1 was successfully constructed.③The recombinant plasmid pBX1 expressed a 29kd fusion protein in E.coli XL1-Blue MRF′after induced with IPTG.The recombinant fusion protein could be recongnized by rabbit polyclonal antiserum against Borrelia burgdorferi B31 strain. Conclusion　A recombinant plasmid which contains the gene fragment encoding the specific region of the 83kd antigen protein from Borrelia burgdorferi B31 strain has been successfully constructed.The recombinant plasmid can stably express 29kd fusion protein in E.coli XL1-Blue MRF′.These results could serve as a base of further studies on the usefulness of the fusion protein in serodiagnosis and vaccine for Lyme disease.